Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME (USD $)	COMMON STOCK [Member]	ADDITIONAL PAID-IN CAPITAL [Member]	DEFICIT [Member]	NON CONTROLLING INTEREST [Member]	Total
Beginning Balance at Oct. 31, 2013	$ 16,432	$ 7,140,150	$ (5,057,677)		$ 2,098,904
Beginning Balance (Shares) at Oct. 31, 2013	16,431,452
Shares issued for PP @ $0.06	500	29,500			30,000lxrp_SharesIssuedForPPSix
Shares issued for PP @ $0.06 (Shares)	500,000
Shares issued for services @ $0.10	1,500	178,500			180,000lxrp_SharesIssuedForServicesOneZero
Shares issued for services @ $0.10 (Shares)	1,500,000
Shares issued for services @ $0.40	150	62,850			63,000lxrp_SharesIssuedForServicesFourZero
Shares issued for services @ $0.40 (Shares)	150,000
Shares issued for services @ $0.60	21	12,479			12,500lxrp_SharesIssuedForServicesSixZero
Shares issued for services @ $0.60 (Shares)	20,833
Shares issued for PP @ $0.12	11,420	1,246,735			1,258,155lxrp_SharesIssuedForPPOneTwo
Shares issued for PP @ $0.12 (Shares)	11,419,999
Shares issued for option exercise @ $0.35	50	17,450			17,500
Shares issued for option exercise @ $0.35 (Shares)	50,000
Stock Options issued @ $0.60		26,112			26,112lxrp_StockOptionsIssuedSixZero
Shares issued for debt conversion @$0.35	552	192,781			193,333
Shares issued for debt conversion @$0.35 (Shares)	552,380
Shares issued per LOI @ $0.40	555	221,445			222,000lxrp_SharesIssuedPerLOIFourZero
Shares issued per LOI @ $0.40 (Shares)	555,000
Shares issued per agreement @ $0.39	110	42,790			42,900lxrp_SharesIssuedPerAgreementThreeNine
Shares issued per agreement @ $0.39 (Shares)	110,000
Shares issued per agreement @ $0.32	550	175,450			176,000lxrp_SharesIssuedPerAgreementThreeTwo
Shares issued per agreement @ $0.32 (Shares)	550,000
Stock Options issued @ $0.25		183,432			183,432lxrp_StockOptionsIssuedTwoFive
Shares issued for option exercise @ $0.10	50	4,950			5,000
Shares issued for option exercise @ $0.10 (Shares)	50,000
Shares issued per agreement @ $0.30	55	16,445			16,500lxrp_SharesIssuedPerAgreementThreeZero
Shares issued per agreement @ $0.30 (Shares)	55,000
Shares issued per agreement @ $0.26	880	263,120			264,000lxrp_SharesIssuedPerAgreementTwoSix
Shares issued per agreement @ $0.26 (Shares)	880,000
Shares issued per LOI @ $0.30	92	27,408			27,500lxrp_SharesIssuedPerLOIThreeZero
Shares issued per LOI @ $0.30 (Shares)	91,662
Shares issued per agreement @ $0.16	82	13,043			13,125lxrp_SharesIssuedPerAgreementOneSix
Shares issued per agreement @ $0.16 (Shares)	82,031
Shares issued for PP @ $0.15	1,250	178,800			180,050lxrp_SharesIssuedForPPOneFive
Shares issued for PP @ $0.15 (Shares)	1,251,333
Shares to be cancelled			(35,200)
Comprehensive income (loss) for the period			(3,257,712)		(3,257,712)us-gaap_ComprehensiveIncomeNetOfTax
Ending Balance at Aug. 31, 2014	34,247	10,033,440	(8,315,389)		1,717,098
Ending Balance (Shares) at Aug. 31, 2014	34,249,690
Shares Cancelled	(110)	(35,090)
Shares Cancelled (Shares)	(110,000)
Shares issued for PP @ $0.15	305	45,475			45,780lxrp_SharesIssuedForPPOneFive
Shares issued for PP @ $0.15 (Shares)	305,200
Investment in ViPova				48,040	48,040lxrp_InvestmentInVipova
Comprehensive income (loss) for the period			(347,249)	(1,906)	(349,155)us-gaap_ComprehensiveIncomeNetOfTax
Ending Balance at Nov. 30, 2014	$ 34,442	$ 10,043,825	$ (8,662,638)	$ 46,134	$ 1,461,763
Ending Balance (Shares) at Nov. 30, 2014	34,444,890